Safety of tissue plasminogen activator for acute stroke in menstruating women

Stroke

Volumn 33, Issue 10, 2002, Pages 2506-2508

  Wein, Theodore H ^a,c   Hickenbottom, Susan L ^a   Morgenstern, Lewis B ^a,b   Demchuk, Andrew M ^a   Grotta, James C ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Hemorrhage; Menstrual cycle; Menstruation; Stroke; Tissue plasminogen activator; Women

Indexed keywords

HEPARIN; PLACEBO; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTERY LIGATION; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG CONTRAINDICATION; DRUG SAFETY; FEMALE; GINGIVA BLEEDING; HUMAN; HYPOTENSION; MENSTRUATION; MENSTRUATION DISORDER; PRIORITY JOURNAL; TACHYCARDIA; TREATMENT OUTCOME; UTERINE ARTERY; UTERUS BLEEDING;

ACUTE DISEASE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; RISK ASSESSMENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036791832     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000030108.47462.4F     Document Type: Article

References (11)

1. Chop WM, Evans PJ, Felty K. Thrombolytic therapy during active menstruation: a case report. J Fam Pract. 1991;33:79-81.
2. Conti CR. Is menstruation a contraindication to thrombolytic therapy? Clin Cardiol. 1992;15:625-626.
3. de Gregorio B, Goldstein J, Haft J. Administration of intracoronary streptokinase during menstruation. Am Heart J. 1985;109:908-910.
4. Karnash SL, Granger CB, White HD, Woodleif LH, Topol EJ, Califf RM. Treating menstruating women with thrombolytic therapy: insights from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial. J Am Coll Cardiol. 1995;26:1651-1656.
5. Lanter PL, Jennings CF, Roberts CS, Jesse RL. Safety of thrombolytic therapy in normally menstruation women with acute myocardial infarction. Am J Cardiol. 1994;74:179-181.
6. Lee DW, Garza JL. Front loaded infusion therapy for rt-PA during active menstruation: a case report. Angiology. 1994;45:311-314.
7. McCallister SH, Lips DL, Linnemeier TJ. Thrombolytic therapy for acute myocardial infarction in actively menstruating women. Ann Intern Med. 1993;119:955. Letter.
8. Sekyema YF, Baltazar RF. Is thrombolytic therapy safe during active menstruation? J Emerg Med. 1995;13:345-348.
9. Simel DL, Moorman JR. Pryor SL. Piscitelli JT, Sharma GVRK. Is streptokinase safe during menses? Arch Intern Med. 1984;144:841-842.
10. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
11. Christiaens GCML, Sixma JJ, Haspels AA. Hemostasis in menstrual endometrium: a review. Obstet Gynecol Surv. 1982;37:281-303.